Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05009992
Title Combination Therapy for the Treatment of Diffuse Midline Gliomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

high grade glioma

diffuse midline glioma, H3 K27M-mutant

brain stem glioma

Therapies

GDC-0084 + ONC201

ONC201 + Panobinostat

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.